Malonylation of GAPDH is an inflammatory signal in macrophages

Silvia Galván-Peña(GlaxoSmithKline (United Kingdom)), Richard G. Carroll(Royal College of Surgeons in Ireland), Carla F. Newman(GlaxoSmithKline (United Kingdom)), Elizabeth C. Hinchy(University of Cambridge), Eva M. Pålsson‐McDermott(Trinity College Dublin), Elektra K. Robinson(University of California, Santa Cruz), Sergio Covarrubias(University of California, Santa Cruz), Alan Nadin(GlaxoSmithKline (United Kingdom)), Andrew M. James(University of Cambridge), Moritz Haneklaus(Trinity College Dublin), Susan Carpenter(University of California, Santa Cruz), Vincent P. Kelly(Trinity College Dublin), Michael P. Murphy(University of Cambridge), Louise K. Modis(GlaxoSmithKline (United Kingdom)), Luke O'neill(GlaxoSmithKline (United Kingdom))
Nature Communications
January 18, 2019
Cited by 200Open Access
Full Text

Abstract

Macrophages undergo metabolic changes during activation that are coupled to functional responses. The gram negative bacterial product lipopolysaccharide (LPS) is especially potent at driving metabolic reprogramming, enhancing glycolysis and altering the Krebs cycle. Here we describe a role for the citrate-derived metabolite malonyl-CoA in the effect of LPS in macrophages. Malonylation of a wide variety of proteins occurs in response to LPS. We focused on one of these, glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In resting macrophages, GAPDH binds to and suppresses translation of several inflammatory mRNAs, including that encoding TNFα. Upon LPS stimulation, GAPDH undergoes malonylation on lysine 213, leading to its dissociation from TNFα mRNA, promoting translation. We therefore identify for the first time malonylation as a signal, regulating GAPDH mRNA binding to promote inflammation.


Related Papers

No related papers found

Powered by citation graph analysis